UNSPSC 51192202: Bendroflumethiazide/potassium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV701. This VA Drug Class (CV701) classifies this compound as belonging to the group THIAZIDES/RELATED DIURETICS.

UNSPSC 51192202 Bendroflumethiazide/potassium chloride is a Commodity code, but the most recent state and local contract opportunities associated with it reflect a significant mismatch between the code's pharmaceutical scope and actual procurement activity. The recent solicitations under this code span industrial valve repair services, parenteral pharmaceutical products and services, and chemical water-treatment supplies — none of which align with the antihypertensive medication the code nominates. State and local purchasing offices appear to be tagging unrelated commodity and service procurements with this code, suggesting either a classification error in the source data or a broader cataloging inconsistency in the jurisdictions posting these opportunities.

The three opportunities posted between mid-August and mid-September 2026 originate from geographically dispersed issuing bodies: Broward County, Florida (wastewater infrastructure); Washington State Department of Corrections (intravenous and parenteral nutrition products across eight regional facilities); and the City of Meriden, Connecticut (municipal water-treatment chemicals). No pattern of repeat buying under this code, no state or local procurement activity in the pharmaceutical medications category that the code actually describes, and no vendors or issuing bodies with a demonstrable focus on bendroflumethiazide/potassium chloride procurement is evident from the recent record. The code shows little relevant recent activity and does not reflect current state and local government purchasing in its stated commodity class.